• FAQs
  • Glossary
Close

FAQs

Why are some conditions more suitable for gene and cell therapies than others?
There is an approved treatment available for my condition - why can't I receive it?
How to look for approved medicines?
How are medicines developed and approved?

See all FAQs

Close

Glossary

Adeno-associated virus (AAV)
Adenovirus
Adult stem cells
Antibody
Antigen
Base editors
Cas9 nuclease
Chimeric Antigen Receptor (CAR)
Chromosome
Clinical trial

See full Glossary

EMA Support for advanced therapy developers

Summarised in this page are a range of advisory services and incentives the European Medicines Agency (EMA) offers for supporting the development of ATMPs.

ema

EMA support for advanced therapy developers

Go to Resource

Back to EMA Resources

Back to Research Pathways

External links

Related pages

EMA teaser

ATMP Overview

Resource
ema

EMA Guidelines relevant for advanced therapy medicinal products

Resource
EMA infosheet

EMA tools for academic medicine developers

Resource
Back to top
Did you find the content on this page useful? If not, you can leave us a message so we can improve Send us your thoughts